+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 22Years - 49Years
All Genders
Healthy Volunteers
ID07860905

Evaluating Repeatability and Reproducibility of Rod Intercept Time Using AdaptDx Pro in Healthy Adults with Normal Vision

Led by AdaptDx, Inc. · Updated on 2026-10-06

16

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the consistency of Rod Intercept RI time measurements using two AdaptDx Pro devices in healthy adults with normal vision. This observational study aims to understand how reliably these devices measure dark adaptation in the eyes of participants aged 22 to 49 years. The study is prospective and conducted at a single center, enrolling sixteen participants with both eyes evaluated independently. Participants will undergo testing with the AdaptDx Pro device, which measures changes in dark adaptation by recording the rod intercept time. Each eye is tested separately to assess repeatability and reproducibility of the measurements. The study focuses on healthy subjects without ocular diseases, using the updated AdaptDx Pro dark adaptation device. During the study, participants will be assessed for visual acuity and ability to follow instructions. The main outcome measured is the Rod Intercept Time immediately after testing. Participants will provide informed consent and comply with study requirements. The trial includes screening and testing visits, with the total study period lasting from September to November 2026.

CONDITIONS

Brief Title

A Study to Test the Repeatability and Reproducibility in Rod Intercept Time Within the AdaptDx Pro in Healthy Subjects With Normal Vision (FlashForward)

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here